000 | 01170 a2200361 4500 | ||
---|---|---|---|
005 | 20250513210244.0 | ||
264 | 0 | _c20000512 | |
008 | 200005s 0 0 eng d | ||
022 | _a0960-314X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPohjalainen, T | |
245 | 0 | 0 |
_aThe dopamine D2 receptor 5'-flanking variant, -141C Ins/Del, is not associated with reduced dopamine D2 receptor density in vivo. _h[electronic resource] |
260 |
_bPharmacogenetics _cAug 1999 |
||
300 |
_a505-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAlleles |
650 | 0 | 4 |
_aCorpus Striatum _xdiagnostic imaging |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 |
_aReceptors, Dopamine D2 _xgenetics |
650 | 0 | 4 |
_aSchizophrenia _xgenetics |
650 | 0 | 4 |
_aSubstance-Related Disorders _xgenetics |
650 | 0 | 4 | _aTomography, Emission-Computed |
700 | 1 | _aNågren, K | |
700 | 1 | _aSyvälahti, E K | |
700 | 1 | _aHietala, J | |
773 | 0 |
_tPharmacogenetics _gvol. 9 _gno. 4 _gp. 505-9 |
|
999 |
_c10733229 _d10733229 |